European Medicines Agency 2017 Annual Report
This report summarizes the work of the EMA for 2017 - in particular addressing issues resultant from UK withdrawal from the EU.
The EMA has accomplished a series of initiatives, including the launch of the EudraVigilance system, in spite of internal changes to the organization and relocation to Amsterdam after Brexit. This document details...
Please Signup/Login to see the full article.Click here